Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis...

Por Sevilla, Isabel, Segura, Ángel, Capdevila, Jaume, López, Carlos, García-Carbonero, Rocío, Grande, Enrique
Publicado no BMC Cancer (2016)

The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review

Por Michael, Michael, Garcia‐Carbonero, Rocio, Weber, Matthias M., Lombard‐Bohas, Catherine, Toumpanakis, Christos, Hicks, Rodney J.
Publicado no Oncologist (2017)

Well-Differentiated Grade 2, Type 3 Gastrointestinal Neuroendocrine Tumour with Bilateral Metastatic Ovarian Involvement: Report of an Unusual Case

Por Manneh, Ray, Castellano, Daniel, Caso, Oscar, Loinaz, Carmelo, Jiménez, Jesús, Estenoz, Juana, Calatayud, Maria, Sepúlveda, Juan M., García-Carbonero, Rocio
Publicado no Case Rep Oncol (2016)

The European Medicines Agency Review of Tegafur/Gimeracil/Oteracil (Teysuno™) for the Treatment of Advanced Gastric Cancer When Given in Combination with Cisplatin: Summary of the...

Por Matt, Petra, van Zwieten-Boot, Barbara, Calvo Rojas, Gonzalo, ter Hofstede, Hadewych, Garcia-Carbonero, Rocio, Camarero, Jorge, Abadie, Eric, Pignatti, Francesco
Publicado em 2011

Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src

Por Perez, Marco, Lucena-Cacace, Antonio, Marín-Gómez, Luis Miguel, Padillo-Ruiz, Javier, Robles-Frias, Maria Jose, Saez, Carmen, Garcia-Carbonero, Rocio, Carnero, Amancio
Publicado no Oncotarget (2016)

Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src

Por Perez, Marco, Lucena-Cacace, Antonio, Marín-Gómez, Luis Miguel, Padillo-Ruiz, Javier, Robles-Frias, Maria Jose, Saez, Carmen, Garcia-Carbonero, Rocio, Carnero, Amancio
Publicado no Oncotarget (2016)

Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in dev...

Por Garcia-Carbonero, Rocio, Garcia-Figueiras, Roberto, Carmona-Bayonas, Alberto, Sevilla, Isabel, Teule, Alex, Quindos, Maria, Grande, Enrique, Capdevila, Jaume, Aller, Javier, Arbizu, Javier, Jimenez-Fonseca, Paula
Publicado no Cancer Metastasis Rev (2015)

Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors

Por Lorenzo, Petra I., Jimenez Moreno, Carmen M., Delgado, Irene, Cobo-Vuilleumier, Nadia, Meier, Raphael, Gomez-Izquierdo, Lourdes, Berney, Thierry, Garcia-Carbonero, Rocio, Rojas, Anabel, Gauthier, Benoit R.
Publicado em 2011

A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced...

Por Gravalos, Cristina, Salut, Antonieta, García-Girón, Carlos, García-Carbonero, Rocío, León, Ana Isabel, Sevilla, Isabel, Maurel, Joan, Esteban, Beatriz, García-Rico, Eduardo, Murias, Adolfo, Cortés-Funes, Hernán
Publicado em 2012

An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer

Por Garcia-Carbonero, Rocio, Rivera, Fernando, Maurel, Joan, Ayoub, Jean-Pierre M., Moore, Malcolm J., Cervantes, Andres, Asmis, Timothy R., Schwartz, Jonathan D., Nasroulah, Federico, Ballal, Shaila, Tabernero, Josep
Publicado em 2014

The European Medicines Agency Review of Abiraterone for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Adult Men After Docetaxel Chemotherapy and in Chemothera...

Por Gravanis, Iordanis, Lopez, Arantxa Sancho, Hemmings, Robert James, Jiménez, Jorge Camarero, Garcia-Carbonero, Rocio, Gallego, Isabel García, Giménez, Elena Valencia, O'Connor, Daniel, Giuliani, Rosa, Salmonson, Tomas, Pignatti, Francesco
Publicado em 2013

Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer

Por Estevez-Garcia, Purificacion, Rivera, Fernando, Molina-Pinelo, Sonia, Benavent, Marta, Gómez, Javier, Limón, Maria Luisa, Pastor, Maria Dolores, Martinez-Perez, Julia, Paz-Ares, Luis, Carnero, Amancio, Garcia-Carbonero, Rocio
Publicado no Oncotarget (2015)

Identification of Oxidative Stress Related Proteins as Biomarkers for Lung Cancer and Chronic Obstructive Pulmonary Disease in Bronchoalveolar Lavage

Por Pastor, Maria Dolores, Nogal, Ana, Molina-Pinelo, Sonia, Meléndez, Ricardo, Romero-Romero, Beatriz, Mediano, Maria Dolores, López-Campos, Jose L., García-Carbonero, Rocío, Sanchez-Gastaldo, Amparo, Carnero, Amancio, Paz-Ares, Luis
Publicado em 2013

PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome

Por Estevez-Garcia Purificacion, Castaño Angel, Martin Ana C, Lopez-Rios Fernando, Iglesias Joaquin, Muñoz-Galván Sandra, Lopez-Calderero Iker, Molina-Pinelo Sonia, Pastor Maria D, Carnero Amancio, Paz-Ares Luis, Garcia-Carbonero Rocio
Publicado em 2012-11-01

PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome

Por Estevez-Garcia, Purificacion, Castaño, Angel, Martin, Ana C, Lopez-Rios, Fernando, Iglesias, Joaquin, Muñoz-Galván, Sandra, Lopez-Calderero, Iker, Molina-Pinelo, Sonia, Pastor, Maria D, Carnero, Amancio, Paz-Ares, Luis, Garcia-Carbonero, Rocio
Publicado em 2012

MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer

Por Molina-Pinelo, Sonia, Gutiérrez, Gabriel, Pastor, Maria Dolores, Hergueta, Marta, Moreno-Bueno, Gema, García-Carbonero, Rocío, Nogal, Ana, Suárez, Rocío, Salinas, Ana, Pozo-Rodríguez, Francisco, Lopez-Rios, Fernando, Agulló-Ortuño, Maria Teresa, Ferrer, Irene, Perpiñá, Asunción, Palacios, José, Carnero, Amancio, Paz-Ares, Luis
Publicado em 2014

MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer

Por Molina-Pinelo, Sonia, Carnero, Amancio, Rivera, Fernando, Estevez-Garcia, Purificacion, Bozada, Juan Manuel, Limon, Maria Luisa, Benavent, Marta, Gomez, Javier, Pastor, Maria Dolores, Chaves, Manuel, Suarez, Rocio, Paz-Ares, Luis, de la Portilla, Fernando, Carranza-Carranza, Andres, Sevilla, Isabel, Vicioso, Luis, Garcia-Carbonero, Rocio
Publicado em 2014

Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First‐Line Metastatic Colorectal Cancer

Por García‐Carbonero, Rocío, van Cutsem, Eric, Rivera, Fernando, Jassem, Jacek, Gore, Ira, Tebbutt, Niall, Braiteh, Fadi, Argiles, Guillem, Wainberg, Zev A., Funke, Roel, Anderson, Maria, McCall, Bruce, Stroh, Mark, Wakshull, Eric, Hegde, Priti, Ye, Weilan, Chen, Daniel, Chang, Ilsung, Rhee, Ina, Hurwitz, Herbert
Publicado no Oncologist (2017)